title: Hypocalcaemic tetany occurring post a single denosumab dose in a patient with stage 4 chronic kidney disease, followed by calcium- and calcitriol-induced hypercalcaemia.
authors.affiliation: General Medicine Department, Rockingham General Hospital, Rockingham, Western Australia, Australia.
authors.forename: Gerard
authors.initials: G
authors.lastname: Lambe
authors.affiliation: General Medicine Department, Rockingham General Hospital, Rockingham, Western Australia, Australia.
authors.forename: Rajasekar
authors.initials: R
authors.lastname: Malvathu
authors.affiliation: General Medicine Department, Rockingham General Hospital, Rockingham, Western Australia, Australia.
authors.forename: Helen M
authors.initials: HM
authors.lastname: Thomas
authors.affiliation: General Medicine Department, Rockingham General Hospital, Rockingham, Western Australia, Australia.
authors.forename: Angela
authors.initials: A
authors.lastname: Graves
mesh_terms: D000369:Aged, 80 and over; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D002117:Calcitriol / Q000009:adverse effects*; D002119:Calcium Carbonate / Q000009:adverse effects*; D002762:Cholecalciferol / Q000009:adverse effects*; D000069448:Denosumab / Q000009:adverse effects*; D005260:Female; D050723:Fractures, Bone / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D006934:Hypercalcemia / Q000097:blood / Q000139:chemically induced* / Q000175:diagnosis; D006996:Hypocalcemia / Q000097:blood / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D008508:Medication Errors; D051436:Renal Insufficiency, Chronic / Q000150:complications* / Q000175:diagnosis; D013746:Tetany / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy
chemical_list: D050071:Bone Density Conservation Agents; D002762:Cholecalciferol; D000069448:Denosumab; D002117:Calcitriol; D002119:Calcium Carbonate